These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12839283)

  • 1. Vincristine in childhood leukaemia: no pharmacokinetic rationale for dose reduction in adolescents.
    Frost BM; Lönnerholm G; Koopmans P; Abrahamsson J; Behrendtz M; Castor A; Forestier E; Uges DR; de Graaf SS
    Acta Paediatr; 2003 May; 92(5):551-7. PubMed ID: 12839283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vincristine pharmacokinetics and response to vincristine monotherapy in an up-front window study of the Dutch Childhood Leukaemia Study Group (DCLSG).
    Groninger E; Meeuwsen-de Boer T; Koopmans P; Uges D; Sluiter W; Veerman A; Kamps W; de Graaf S
    Eur J Cancer; 2005 Jan; 41(1):98-103. PubMed ID: 15617994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vincristine pharmacokinetics is related to clinical outcome in children with standard risk acute lymphoblastic leukemia.
    Lönnerholm G; Frost BM; Abrahamsson J; Behrendtz M; Castor A; Forestier E; Heyman M; Uges DR; de Graaf SS
    Br J Haematol; 2008 Aug; 142(4):616-21. PubMed ID: 18537965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of vincristine monotherapy in childhood acute lymphoblastic leukemia.
    Groninger E; Meeuwsen-de Boar T; Koopmans P; Uges D; Sluiter W; Veerman A; Kamps W; de Graaf S
    Pediatr Res; 2002 Jul; 52(1):113-8. PubMed ID: 12084857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vincristine pharmacokinetics after repetitive dosing in children.
    Gidding CE; Meeuwsen-de Boer GJ; Koopmans P; Uges DR; Kamps WA; de Graaf SS
    Cancer Chemother Pharmacol; 1999; 44(3):203-9. PubMed ID: 10453721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vincristine pharmacodynamics and pharmacogenetics in children with cancer: a limited-sampling, population modelling approach.
    Moore AS; Norris R; Price G; Nguyen T; Ni M; George R; van Breda K; Duley J; Charles B; Pinkerton R
    J Paediatr Child Health; 2011 Dec; 47(12):875-82. PubMed ID: 21658147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vincristine pharmacokinetics in children with Down syndrome.
    Lönnerholm G; Frost BM; Söderhäll S; de Graaf SS
    Pediatr Blood Cancer; 2009 Jan; 52(1):123-5. PubMed ID: 18615507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in motor performance in children with cancer is independent of the cumulative dose of vincristine.
    Hartman A; van den Bos C; Stijnen T; Pieters R
    Cancer; 2006 Mar; 106(6):1395-401. PubMed ID: 16453332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of functional polymorphisms of the MDR1 gene on vincristine pharmacokinetics in childhood acute lymphoblastic leukemia.
    Plasschaert SL; Groninger E; Boezen M; Kema I; de Vries EG; Uges D; Veerman AJ; Kamps WA; Vellenga E; de Graaf SS; de Bont ES
    Clin Pharmacol Ther; 2004 Sep; 76(3):220-9. PubMed ID: 15371983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of doxorubicin in children with acute lymphoblastic leukemia: multi-institutional collaborative study.
    Frost BM; Eksborg S; Björk O; Abrahamsson J; Behrendtz M; Castor A; Forestier E; Lönnerholm G
    Med Pediatr Oncol; 2002 May; 38(5):329-37. PubMed ID: 11979457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and urinary excretion of vincristine sulfate liposomes injection in metastatic melanoma patients.
    Bedikian AY; Vardeleon A; Smith T; Campbell S; Namdari R
    J Clin Pharmacol; 2006 Jul; 46(7):727-37. PubMed ID: 16809798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia.
    Petersen KB; Jusko WJ; Rasmussen M; Schmiegelow K
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):465-73. PubMed ID: 12698270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic behavior of vincristine sulfate following administration of vincristine sulfate liposome injection.
    Embree L; Gelmon K; Tolcher A; Hudon N; Heggie J; Dedhar C; Logan P; Bally MB; Mayer LD
    Cancer Chemother Pharmacol; 1998; 41(5):347-52. PubMed ID: 9523729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia.
    Thomas DA; Sarris AH; Cortes J; Faderl S; O'Brien S; Giles FJ; Garcia-Manero G; Rodriguez MA; Cabanillas F; Kantarjian H
    Cancer; 2006 Jan; 106(1):120-7. PubMed ID: 16331634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
    Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
    Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study.
    Tedeschi A; Montillo M; Strocchi E; Cafro AM; Tresoldi E; Intropido L; Nichelatti M; Marbello L; Baratè C; Camaggi CM; Morra E
    Cancer Chemother Pharmacol; 2007 May; 59(6):771-9. PubMed ID: 17256136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etoposide pharmacokinetics in children: the development and prospective validation of a dosing equation.
    Lowis SP; Pearson AD; Newell DR; Cole M
    Cancer Res; 1993 Oct; 53(20):4881-9. PubMed ID: 8402676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild axonal neuropathy of children during treatment for acute lymphoblastic leukaemia.
    Reinders-Messelink HA; Van Weerden TW; Fock JM; Gidding CE; Vingerhoets HM; Schoemaker MM; Göeken LN; Bökkerink JP; Kamps WA
    Eur J Paediatr Neurol; 2000; 4(5):225-33. PubMed ID: 11030069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients.
    Harnicar S; Adel N; Jurcic J
    J Oncol Pharm Pract; 2009 Sep; 15(3):175-82. PubMed ID: 19282418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.